A high-throughput screen to identify inhibitors of ATP homeostasis in non-replicating mycobacterium tuberculosis

ACS Chemical Biology

Volumn 7, Issue 7, 2012, Pages 1190-1197

  Mak, Puiying A ^a   Rao, Srinivasa P S ^b   Ping Tan, Mai ^b,d   Lin, Xiuhua ^b   Chyba, Jason ^a   Tay, Joann ^b   Ng, Seow Hwee ^b   Tan, Bee Huat ^b   Cherian, Joseph ^b,e   Duraiswamy, Jeyaraj ^b,e   Bifani, Pablo ^b   Lim, Vivian ^b   Lee, Boon Heng ^b   Ling Ma, Ngai ^b   Beer, David ^b   Thayalan, Pamela ^b   Kuhen, Kelli ^a   Chatterjee, Arnab ^a   Supek, Frantisek ^a   Glynne, Richard ^a   Zheng, Jun ^b   Boshoff, Helena I ^c   Barry, Clifton E ^c   Dick, Thomas ^b,f   Pethe, Kevin ^b,g   Camacho, Luis R ^b   more..

^a GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^b NOVARTIS INSTITUTE FOR TROPICAL DISEASES   (Singapore)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

^d CARDIFF UNIVERSITY   (United Kingdom)

^e Agency for Science   (Singapore)

^f NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^g Institute Pasteur Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ARTICLE; BREATHING; CONTROLLED STUDY; CYTOTOXICITY; HIGH THROUGHPUT SCREENING; HYPOXIA; IC 50; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN HOMEOSTASIS; VALIDATION PROCESS;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTITUBERCULAR AGENTS; CELL SURVIVAL; CHO CELLS; CRICETINAE; CRICETULUS; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HOMEOSTASIS; HUMANS; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS;

BACTERIA (MICROORGANISMS); CORYNEBACTERINEAE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS;

EID: 84864128973     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb2004884     Document Type: Article

References (42)

1. Dye, C., Scheele, S., Dolin, P., Pathania, V., and Raviglione, M. C. (1999) Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project J. Am. Med. Assoc. 282, 677-686
2. Mahmoudi, A. and Iseman, M. D. (1993) Pitfalls in the care of patients with tuberculosis. Common errors and their association with the acquisition of drug resistance J. Am. Med. Assoc. 270, 65-68
3. Duncan, K. and Barry, C. E., III (2004) Prospects for new antitubercular drugs Curr. Opin. Microbiol. 7, 460-465
4. Young, D. B., Perkins, M. D., Duncan, K., and Barry, C. E., III (2008) Confronting the scientific obstacles to global control of tuberculosis J. Clin. Invest. 118, 1255-1265
5. Gomez, J. E. and McKinney, J. D. M. (2004) Tuberculosis persistence, latency, and drug tolerance Tuberculosis (Edinburgh) 84, 29-44
6. Dick, T. (2001) Dormant tubercle bacilli: the key to more effective TB chemotherapy? J. Antimicrob. Chemother. 47, 117-118
7. Boshoff, H. I. and Barry, C. E., III (2005) Tuberculosis-metabolism and respiration in the absence of growth Nat. Rev. Microbiol. 3, 70-80
8. Wayne, L. G. and Sohaskey, C. D. (2001) Nonreplicating persistence of mycobacterium tuberculosis Annu. Rev. Microbiol. 55, 139-163
9. Heng, Y., Seah, P. G., Siew, J. Y., Tay, H. C., Singhal, A., Mathys, V., Kiass, M., Bifani, P., Dartois, V., and Herve, M. (2011) Mycobacterium tuberculosis infection induces hypoxic lung lesions in the rat Tuberculosis (Edinburgh) 91, 339-341
10. Via, L. E., Lin, P. L., Ray, S. M., Carrillo, J., Allen, S. S., Eum, S. Y., Taylor, K., Klein, E., Manjunatha, U., Gonzales, J., Lee, E. G., Park, S. K., Raleigh, J. A., Cho, S. N., McMurray, D. N., Flynn, J. L., and Barry, C. E., III (2008) Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates Infect. Immun. 76, 2333-2340
11. Park, H. D., Guinn, K. M., Harrell, M. I., Liao, R., Voskuil, M. I., Tompa, M., Schoolnik, G. K., and Sherman, D. R. (2003) Rv3133c/dosR is a transcription factor that mediates the hypoxic response of Mycobacterium tuberculosis Mol. Microbiol. 48, 833-843
12. Muttucumaru, D. G., Roberts, G., Hinds, J., Stabler, R. A., and Parish, T. (2004) Gene expression profile of Mycobacterium tuberculosis in a non-replicating state Tuberculosis (Edinburgh) 84, 239-246
13. Schnappinger, D., Ehrt, S., Voskuil, M. I., Liu, Y., Mangan, J. A., Monahan, I. M., Dolganov, G., Efron, B., Butcher, P. D., Nathan, C., and Schoolnik, G. K. (2003) Transcriptional adaptation of Mycobacterium tuberculosis within macrophages: Insights into the phagosomal environment J. Exp. Med. 198, 693-704
14. Leistikow, R. L., Morton, R. A., Bartek, I. L., Frimpong, I., Wagner, K., and Voskuil, M. I. (2010) The Mycobacterium tuberculosis DosR regulon assists in metabolic homeostasis and enables rapid recovery from nonrespiring dormancy J. Bacteriol. 192, 1662-1670
15. Rustad, T. R., Harrell, M. I., Liao, R., and Sherman, D. R. (2008) The enduring hypoxic response of Mycobacterium tuberculosis PLoS One 3, e1502
16. Rao, S. P., Alonso, S., Rand, L., Dick, T., and Pethe, K. (2008) The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis Proc. Natl. Acad. Sci. U.S.A. 105, 11945-11950
17. Watanabe, S., Zimmermann, M., Goodwin, M. B., Sauer, U., Barry, C. E., Boshoff, I. I. I., and Fumarate Reductase, H. I. (2011) Activity maintains an energized membrane in anaerobic Mycobacterium tuberculosis PLoS Pathog. 7, e1002287
18. Diacon, A. H., Pym, A., Grobusch, M., Patientia, R., Rustomjee, R., Page-Shipp, L., Pistorius, C., Krause, R., Bogoshi, M., Churchyard, G., Venter, A., Allen, J., Palomino, J. C., De, M. T., van Heeswijk, R. P., Lounis, N., Meyvisch, P., Verbeeck, J., Parys, W., de, B. K., Andries, K., and Mc Neeley, D. F. (2009) The diarylquinoline TMC207 for multidrug-resistant tuberculosis N. Engl. J. Med. 360, 2397-2405
19. Andries, K., Verhasselt, P., Guillemont, J., Gohlmann, H. W., Neefs, J. M., Winkler, H., Van Gestel, J., Timmerman, P., Zhu, M., Lee, E., Williams, P., de Chaffoy, D., Huitric, E., Hoffner, S., Cambau, E., Truffot-Pernot, C., Lounis, N., and Jarlier, V. (2005) A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis Science 307, 223-227
20. Wayne, L. G. (1977) Synchronized replication of Mycobacterium tuberculosis Infect. Immun. 17, 528-530
21. Wayne, L. G. and Lin, K. Y. (1982) Glyoxylate metabolism and adaptation of Mycobacterium tuberculosis to survival under anaerobic conditions Infect. Immun. 37, 1042-1049
22. Wayne, L. G. and Hayes, L. G. (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence Infect. Immun. 64, 2062-2069
23. Tan, M. P., Sequeira, P., Lin, W. W., Phong, W. Y., Cliff, P., Ng, S. H., Lee, B. H., Camacho, L., Schnappinger, D., Ehrt, S., Dick, T., Pethe, K., and Alonso, S. (2010) Nitrate respiration protects hypoxic Mycobacterium tuberculosis against acid- and reactive nitrogen species stresses PLoS One 5, e13356
24. Wayne, L. G. and Hayes, L. G. (1996) An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence Infect. Immun. 64, 2062-2069
25. Boon, C. and Dick, T. (2002) Mycobacterium bovis BCG response regulator essential for hypoxic dormancy J. Bacteriol. 184, 6760-6767
26. Malhotra, V., Sharma, D., Ramanathan, V. D., Shakila, H., Saini, D. K., Chakravorty, S., Das, T. K., Li, Q., Silver, R. F., Narayanan, P. R., and Tyagi, J. S. (2004) Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis FEMS Microbiol. Lett. 231, 237-245
27. Roberts, D. M., Liao, R. P., Wisedchaisri, G., Hol, W. G., and Sherman, D. R. (2004) Two sensor kinases contribute to the hypoxic response of Mycobacterium tuberculosis J. Biol. Chem. 279, 23082-23087
28. Sherman, D. R., Voskuil, M., Schnappinger, D., Liao, R., Harrell, M. I., and Schoolnik, G. K. (2001) Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding alpha -Crystallin Proc. Natl. Acad. Sci. U.S.A. 98, 7534-7539
29. Stermann, M., Bohrssen, A., Diephaus, C., Maass, S., and Bange, F. C. (2003) Polymorphic nucleotide within the promoter of nitrate reductase (NarGHJI) is specific for Mycobacterium tuberculosis J. Clin. Microbiol. 41, 3252-3259
30. Manjunatha, U., Boshoff, H. I., and Barry, C. E. (2009) The mechanism of action of PA-824: Novel insights from transcriptional profiling Commun. Integr. Biol 2, 215-218
31. Garnier, T., Eiglmeier, K., Camus, J. C., Medina, N., Mansoor, H., Pryor, M., Duthoy, S., Grondin, S., Lacroix, C., Monsempe, C., Simon, S., Harris, B., Atkin, R., Doggett, J., Mayes, R., Keating, L., Wheeler, P. R., Parkhill, J., Barrell, B. G., Cole, S. T., Gordon, S. V., and Hewinson, R. G. (2003) The complete genome sequence of Mycobacterium bovis Proc. Natl. Acad. Sci. U.S.A. 100, 7877-7882
32. Boshoff, H. I., Mizrahi, V., and Barry, C. E., III (2002) Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I J. Bacteriol. 184, 2167-2172
33. Scorpio, A. and Zhang, Y. (1996) Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus Nat. Med. 2, 662-667
34. MedChem Studio, 2.0.0.1 (2011) Simulations Plus, Inc., Lancaster, CA.
35. Khoje, A. D., Charnock, C., Wan, B., Franzblau, S., and Gundersen, L. L. (2011) Synthesis and antimycobacterial activities of non-purine analogs of 6-aryl-9-benzylpurines: Imidazopyridines, pyrrolopyridines, benzimidazoles, and indoles Bioorg. Med. Chem. 19, 3483-3491
36. Pieroni, M., Lilienkampf, A., Wan, B., Wang, Y., Franzblau, S. G., and Kozikowski, A. P. (2009) Synthesis, biological evaluation, and structure-activity relationships for 5-[(E)-2-arylethenyl]-3-isoxazolecarboxylic acid alkyl ester derivatives as valuable antitubercular chemotypes J. Med. Chem. 52, 6287-6296
37. Maddry, J. A., Ananthan, S., Goldman, R. C., Hobrath, J. V., Kwong, C. D., Maddox, C., Rasmussen, L., Reynolds, R. C., Secrist, J. A., III, Sosa, M. I., White, E. L., and Zhang, W. (2009) Antituberculosis activity of the molecular libraries screening center network library Tuberculosis (Edinburgh) 89, 354-363
38. Moraski, G. C., Markley, L. D., Hipskind, P. A., Boshoff, H., Cho, S., Franzblau, S. G., and Miller, M. J. (2011) Advent of imidazo[1,2- a ]pyridine-3-carboxamides with potent multi- and extended drug resistant antituberculosis activity ACS Med. Chem. Lett. 2, 466-470
39. Koul, A., Dendouga, N., Vergauwen, K., Molenberghs, B., Vranckx, L., Willebrords, R., Ristic, Z., Lill, H., Dorange, I., Guillemont, J., Bald, D., and Andries, K. (2007) Diarylquinolines target subunit c of mycobacterial ATP synthase Nat. Chem. Biol. 3, 323-324
40. Bardarov, S., Bardarov, S, Jr, Pavelka, M. S. J., Jr, Sambandamurthy, V., Larsen, M., Tufariello, J., Chan, J., Hatfull, G., and Jacobs, W. R. J., Jr (2002) Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis Microbiology 148, 3007-3017
41. Parish, T. and Stoker, N. G. (2000) Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement Microbiology 146 (Pt 8) 1969-1975
42. Stover, C. K., de la Cruz, V. F., Fuerst, T. R., Burlein, J. E., Benson, L. A., Bennett, L. T., Bansal, G. P., Young, J. F., Lee, M. H., and Hatfull, G. F. (1991) New use of BCG for recombinant vaccines Nature 351, 456-460